BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 13, 2002
View Archived Issues
Remedyne licenses Bayer antigen for use in cancer immunotherapeutic
Read More
Biovitrum initiates phase I trials of BVT-3498
Read More
NGD-96-3 enters phase I trials
Read More
OrthoLogic's IND approved for phase I/II trial of Chrysalin in spinal fusion
Read More
Synt:em licenses Pep:trans technology to Corixa for vaccine development
Read More
Recent studies support first-line use of tiotropium as maintenance therapy in COPD patients
Read More
Synthetic peptide sensitizes leukemia cell lines to hyperthermia
Read More
Superiority of enoxaparin over unfractionated heparin sustained over one year
Read More
Inhibition of membrane synthesis as a target for the development of new antimalarials
Read More
Calcilytic compounds presented as a new therapy for bone and mineral diseases
Read More
New compounds for the treatment of CNS disorders reported by Lundbeck
Read More
Investigators at Banyu identify a series of selective muscarinic M3 receptor antagonists
Read More
Serine protease inhibitors of HCV reported by Schering-Plough and Corvas
Read More
New lead cPLA2 inhibitor designed at AstraZeneca
Read More
Leukocyte adhesion inhibitors reported useful for a wide range of inflammatory diseases
Read More
Update of Miravant's ophthalmology, dermatology and cardiovascular PhotoPoint programs
Read More
Promising preclinical results for Celgene's JNK inhibitors
Read More
Ad5FGF4 improves myocardial perfusion in phase II trial
Read More
Atrix licenses Israeli Eligard marketing rights to Luxembourg
Read More
Serono reintroduces Crinone in U.S.
Read More
SBIR grant for research into ATL-146e in prevention of injury from spinal cord ischemia
Read More
CPMP recommends approval of irbesartan in diabetic renal disease
Read More
PowderJect submits MAA for Dukoral cholera and travel diarrhea vaccine
Read More
Myriad Genetics and Abbott collaborate to discover drugs for depression
Read More
Essential Therapeutics completes acquisition of Maret
Read More